Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000126 | transcription factor TFIIIB complex | 4 | 2 |
GO:0005634 | nucleus | 5 | 2 |
GO:0005667 | transcription regulator complex | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0032993 | protein-DNA complex | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0090576 | RNA polymerase III transcription regulator complex | 3 | 2 |
GO:0097550 | transcription preinitiation complex | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QF67
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006351 | DNA-templated transcription | 7 | 2 |
GO:0006352 | DNA-templated transcription initiation | 6 | 2 |
GO:0006383 | transcription by RNA polymerase III | 8 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009058 | biosynthetic process | 2 | 2 |
GO:0009059 | macromolecule biosynthetic process | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0018130 | heterocycle biosynthetic process | 4 | 2 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 2 |
GO:0032774 | RNA biosynthetic process | 5 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044249 | cellular biosynthetic process | 3 | 2 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:0097659 | nucleic acid-templated transcription | 6 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 2 |
GO:1901576 | organic substance biosynthetic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000976 | transcription cis-regulatory region binding | 5 | 2 |
GO:0000987 | cis-regulatory region sequence-specific DNA binding | 6 | 2 |
GO:0000992 | RNA polymerase III cis-regulatory region sequence-specific DNA binding | 7 | 2 |
GO:0000995 | RNA polymerase III general transcription initiation factor activity | 2 | 2 |
GO:0001006 | RNA polymerase III type 3 promoter sequence-specific DNA binding | 8 | 2 |
GO:0001016 | RNA polymerase III transcription regulatory region sequence-specific DNA binding | 6 | 2 |
GO:0001067 | transcription regulatory region nucleic acid binding | 4 | 2 |
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003677 | DNA binding | 4 | 2 |
GO:0003690 | double-stranded DNA binding | 5 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0043565 | sequence-specific DNA binding | 5 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:0140223 | general transcription initiation factor activity | 1 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
GO:1990837 | sequence-specific double-stranded DNA binding | 6 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 212 | 216 | PF00656 | 0.357 |
CLV_NRD_NRD_1 | 141 | 143 | PF00675 | 0.398 |
CLV_NRD_NRD_1 | 162 | 164 | PF00675 | 0.305 |
CLV_NRD_NRD_1 | 209 | 211 | PF00675 | 0.280 |
CLV_NRD_NRD_1 | 406 | 408 | PF00675 | 0.765 |
CLV_PCSK_KEX2_1 | 141 | 143 | PF00082 | 0.382 |
CLV_PCSK_KEX2_1 | 162 | 164 | PF00082 | 0.327 |
CLV_PCSK_KEX2_1 | 209 | 211 | PF00082 | 0.280 |
CLV_PCSK_KEX2_1 | 408 | 410 | PF00082 | 0.638 |
CLV_PCSK_PC1ET2_1 | 408 | 410 | PF00082 | 0.638 |
CLV_PCSK_PC7_1 | 404 | 410 | PF00082 | 0.543 |
CLV_PCSK_SKI1_1 | 119 | 123 | PF00082 | 0.485 |
CLV_PCSK_SKI1_1 | 314 | 318 | PF00082 | 0.551 |
CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.521 |
DOC_CKS1_1 | 354 | 359 | PF01111 | 0.447 |
DOC_CYCLIN_yCln2_LP_2 | 187 | 193 | PF00134 | 0.411 |
DOC_MAPK_gen_1 | 162 | 169 | PF00069 | 0.411 |
DOC_MAPK_MEF2A_6 | 128 | 137 | PF00069 | 0.494 |
DOC_MAPK_MEF2A_6 | 282 | 289 | PF00069 | 0.322 |
DOC_PP1_RVXF_1 | 293 | 299 | PF00149 | 0.495 |
DOC_PP2B_LxvP_1 | 242 | 245 | PF13499 | 0.410 |
DOC_USP7_MATH_1 | 104 | 108 | PF00917 | 0.548 |
DOC_USP7_MATH_1 | 127 | 131 | PF00917 | 0.402 |
DOC_USP7_MATH_1 | 17 | 21 | PF00917 | 0.407 |
DOC_USP7_MATH_1 | 176 | 180 | PF00917 | 0.456 |
DOC_USP7_MATH_1 | 269 | 273 | PF00917 | 0.581 |
DOC_USP7_MATH_1 | 306 | 310 | PF00917 | 0.568 |
DOC_USP7_MATH_1 | 339 | 343 | PF00917 | 0.570 |
DOC_USP7_MATH_1 | 370 | 374 | PF00917 | 0.728 |
DOC_USP7_MATH_1 | 386 | 390 | PF00917 | 0.719 |
DOC_WW_Pin1_4 | 353 | 358 | PF00397 | 0.527 |
DOC_WW_Pin1_4 | 413 | 418 | PF00397 | 0.779 |
LIG_14-3-3_CanoR_1 | 128 | 136 | PF00244 | 0.421 |
LIG_14-3-3_CanoR_1 | 411 | 417 | PF00244 | 0.750 |
LIG_14-3-3_CanoR_1 | 78 | 86 | PF00244 | 0.634 |
LIG_Actin_WH2_2 | 189 | 206 | PF00022 | 0.411 |
LIG_APCC_ABBA_1 | 274 | 279 | PF00400 | 0.450 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.425 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.502 |
LIG_FHA_1 | 414 | 420 | PF00498 | 0.724 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.413 |
LIG_FHA_2 | 200 | 206 | PF00498 | 0.409 |
LIG_FHA_2 | 364 | 370 | PF00498 | 0.637 |
LIG_FHA_2 | 47 | 53 | PF00498 | 0.576 |
LIG_FHA_2 | 54 | 60 | PF00498 | 0.498 |
LIG_FHA_2 | 85 | 91 | PF00498 | 0.638 |
LIG_LIR_Gen_1 | 349 | 357 | PF02991 | 0.446 |
LIG_LIR_Gen_1 | 54 | 61 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 134 | 139 | PF02991 | 0.357 |
LIG_LIR_Nem_3 | 349 | 353 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 381 | 387 | PF02991 | 0.596 |
LIG_LIR_Nem_3 | 54 | 60 | PF02991 | 0.477 |
LIG_PTAP_UEV_1 | 396 | 401 | PF05743 | 0.663 |
LIG_REV1ctd_RIR_1 | 134 | 142 | PF16727 | 0.357 |
LIG_SH2_CRK | 384 | 388 | PF00017 | 0.602 |
LIG_SH2_NCK_1 | 57 | 61 | PF00017 | 0.505 |
LIG_SH2_PTP2 | 238 | 241 | PF00017 | 0.400 |
LIG_SH2_SRC | 384 | 387 | PF00017 | 0.626 |
LIG_SH2_SRC | 57 | 60 | PF00017 | 0.500 |
LIG_SH2_STAP1 | 318 | 322 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 14 | 17 | PF00017 | 0.456 |
LIG_SH2_STAT5 | 238 | 241 | PF00017 | 0.352 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.499 |
LIG_SH3_3 | 296 | 302 | PF00018 | 0.600 |
LIG_SH3_3 | 394 | 400 | PF00018 | 0.781 |
LIG_SH3_3 | 414 | 420 | PF00018 | 0.650 |
LIG_TRAF2_1 | 424 | 427 | PF00917 | 0.608 |
LIG_TRAF2_1 | 87 | 90 | PF00917 | 0.634 |
LIG_WRC_WIRS_1 | 318 | 323 | PF05994 | 0.361 |
MOD_CK1_1 | 107 | 113 | PF00069 | 0.544 |
MOD_CK1_1 | 20 | 26 | PF00069 | 0.448 |
MOD_CK1_1 | 320 | 326 | PF00069 | 0.477 |
MOD_CK1_1 | 395 | 401 | PF00069 | 0.702 |
MOD_CK1_1 | 412 | 418 | PF00069 | 0.624 |
MOD_CK1_1 | 422 | 428 | PF00069 | 0.804 |
MOD_CK2_1 | 363 | 369 | PF00069 | 0.603 |
MOD_CK2_1 | 46 | 52 | PF00069 | 0.625 |
MOD_CK2_1 | 84 | 90 | PF00069 | 0.647 |
MOD_DYRK1A_RPxSP_1 | 413 | 417 | PF00069 | 0.750 |
MOD_GlcNHglycan | 109 | 112 | PF01048 | 0.523 |
MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.406 |
MOD_GlcNHglycan | 307 | 311 | PF01048 | 0.619 |
MOD_GlcNHglycan | 394 | 397 | PF01048 | 0.764 |
MOD_GlcNHglycan | 422 | 425 | PF01048 | 0.713 |
MOD_GSK3_1 | 306 | 313 | PF00069 | 0.568 |
MOD_GSK3_1 | 316 | 323 | PF00069 | 0.490 |
MOD_GSK3_1 | 391 | 398 | PF00069 | 0.755 |
MOD_GSK3_1 | 407 | 414 | PF00069 | 0.731 |
MOD_NEK2_1 | 114 | 119 | PF00069 | 0.525 |
MOD_NEK2_1 | 137 | 142 | PF00069 | 0.411 |
MOD_NEK2_1 | 199 | 204 | PF00069 | 0.376 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.407 |
MOD_NEK2_1 | 317 | 322 | PF00069 | 0.536 |
MOD_PIKK_1 | 422 | 428 | PF00454 | 0.613 |
MOD_PKA_1 | 407 | 413 | PF00069 | 0.739 |
MOD_PKA_2 | 127 | 133 | PF00069 | 0.436 |
MOD_PKA_2 | 137 | 143 | PF00069 | 0.426 |
MOD_PKA_2 | 412 | 418 | PF00069 | 0.738 |
MOD_PKA_2 | 77 | 83 | PF00069 | 0.644 |
MOD_PKB_1 | 407 | 415 | PF00069 | 0.696 |
MOD_Plk_1 | 339 | 345 | PF00069 | 0.298 |
MOD_Plk_1 | 53 | 59 | PF00069 | 0.477 |
MOD_Plk_4 | 176 | 182 | PF00069 | 0.383 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.517 |
MOD_ProDKin_1 | 353 | 359 | PF00069 | 0.523 |
MOD_ProDKin_1 | 413 | 419 | PF00069 | 0.779 |
MOD_SUMO_for_1 | 376 | 379 | PF00179 | 0.656 |
MOD_SUMO_rev_2 | 379 | 383 | PF00179 | 0.669 |
TRG_DiLeu_BaEn_1 | 349 | 354 | PF01217 | 0.510 |
TRG_DiLeu_BaEn_2 | 272 | 278 | PF01217 | 0.467 |
TRG_DiLeu_BaLyEn_6 | 237 | 242 | PF01217 | 0.388 |
TRG_DiLeu_BaLyEn_6 | 341 | 346 | PF01217 | 0.506 |
TRG_ENDOCYTIC_2 | 238 | 241 | PF00928 | 0.454 |
TRG_ENDOCYTIC_2 | 318 | 321 | PF00928 | 0.379 |
TRG_ENDOCYTIC_2 | 384 | 387 | PF00928 | 0.600 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.500 |
TRG_ER_diArg_1 | 161 | 163 | PF00400 | 0.283 |
TRG_NLS_MonoExtC_3 | 406 | 411 | PF00514 | 0.668 |
TRG_NLS_MonoExtN_4 | 404 | 411 | PF00514 | 0.748 |
TRG_Pf-PMV_PEXEL_1 | 258 | 262 | PF00026 | 0.482 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I166 | Leptomonas seymouri | 67% | 100% |
A0A1X0NU06 | Trypanosomatidae | 37% | 100% |
A0A3R7MLE9 | Trypanosoma rangeli | 39% | 100% |
A0A3S5H6V5 | Leishmania donovani | 95% | 100% |
A4H880 | Leishmania braziliensis | 83% | 100% |
A4HWK6 | Leishmania infantum | 95% | 100% |
C9ZXT3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 100% |
E9AQA7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
V5BK49 | Trypanosoma cruzi | 38% | 100% |